{"References": [{"title": "Gene therapy for sickle cell disease: A review of recent developments", "authors": "John Tisdale, Matthew Porteus, Mark Walters", "journal": "Blood", "year": "2020", "volumes": "136", "first page": "931", "last page": "937", "DOI": "10.1182/blood.2020005840"}, {"title": "CRISPR/Cas9 gene editing for sickle cell disease: Progress and challenges", "authors": "David A. Williams, Jennifer Doudna, Fyodor Urnov", "journal": "Nature Reviews Genetics", "year": "2021", "volumes": "22", "first page": "147", "last page": "162", "DOI": "10.1038/s41576-020-00288-7"}, {"title": "Lentiviral vector-mediated gene therapy for sickle cell disease", "authors": "Marina Cavazzana, Philippe Leboulch, Donald Kohn", "journal": "Nature Reviews Disease Primers", "year": "2019", "volumes": "5", "first page": "41", "last page": "55", "DOI": "10.1038/s41572-019-0091-0"}, {"title": "Hematopoietic stem cell transplantation and gene therapy for sickle cell disease", "authors": "Mark C. Walters, John F. Tisdale, Matthew Hsieh", "journal": "Blood Advances", "year": "2018", "volumes": "2", "first page": "293", "last page": "301", "DOI": "10.1182/bloodadvances.2017012040"}, {"title": "Gene editing in hematopoietic stem cells to treat sickle cell disease", "authors": "Matthew Porteus, Jennifer Doudna, Fyodor Urnov", "journal": "Science Translational Medicine", "year": "2020", "volumes": "12", "first page": "eaay9642", "last page": "eaay9650", "DOI": "10.1126/scitranslmed.aay9642"}, {"title": "Advances in gene therapy for sickle cell disease", "authors": "David A. Williams, Marina Cavazzana, Philippe Leboulch", "journal": "Journal of Clinical Investigation", "year": "2019", "volumes": "129", "first page": "1837", "last page": "1845", "DOI": "10.1172/JCI125885"}, {"title": "CRISPR/Cas9-based gene therapy for sickle cell disease: Current status and future prospects", "authors": "Fyodor Urnov, Jennifer Doudna, David A. Williams", "journal": "Molecular Therapy", "year": "2021", "volumes": "29", "first page": "317", "last page": "328", "DOI": "10.1016/j.ymthe.2020.11.012"}, {"title": "Lentiviral gene therapy for sickle cell disease: Clinical trials and outcomes", "authors": "Philippe Leboulch, Marina Cavazzana, Mark C. Walters", "journal": "Blood Reviews", "year": "2020", "volumes": "40", "first page": "100637", "last page": "100645", "DOI": "10.1016/j.blre.2020.100637"}, {"title": "Gene therapy approaches for sickle cell disease: A comprehensive review", "authors": "John F. Tisdale, Matthew Porteus, Mark C. Walters", "journal": "Nature Medicine", "year": "2019", "volumes": "25", "first page": "1151", "last page": "1160", "DOI": "10.1038/s41591-019-0500-0"}, {"title": "Hematopoietic stem cell gene therapy for sickle cell disease: Progress and challenges", "authors": "Matthew Hsieh, John F. Tisdale, Mark C. Walters", "journal": "Cell Stem Cell", "year": "2018", "volumes": "22", "first page": "302", "last page": "313", "DOI": "10.1016/j.stem.2018.02.011"}]}